Related Experiment Video
Updated: Jan 9, 2026

03:14
Augmenting Large Language Models via Vector Embeddings to Improve Domain-Specific Responsiveness
Published on: December 6, 2024
994
Reimagining Cancer Care With Generative Artificial Intelligence: The Promise of Large Language Models.
Ji-Eun Irene Yum1, Syed Arsalan Ahmed Naqvi1, Ben Zhou2
1Mayo Clinic, Phoenix, AZ.
JCO Clinical Cancer Informatics
|December 1, 2025
Summary
Large language models (LLMs) offer new opportunities in cancer care by analyzing extensive patient data. Future research should focus on patient perspectives and real-world testing for safe integration.
Area of Science:
- Artificial Intelligence in Medicine
- Oncology Informatics
Background:
- Large language models (LLMs) demonstrate advanced natural language processing capabilities, opening new avenues in healthcare.
- Cancer patient journeys generate rich, longitudinal data, ideal for LLM analysis.
Purpose of the Study:
- To review fundamental concepts of LLMs, including architecture, training, and optimization.
- To explore the application of LLMs in oncology for patients, clinicians, researchers, and learners.
- To address the limitations and risks associated with LLM implementation in cancer care.
Main Methods:
- Review of LLM fundamentals: definitions, architecture, training, and optimization techniques (prompt engineering, retrieval-augmented generation).
- Exploration of multiagentic frameworks for LLMs.
- Synthesis of current research on LLM benefits and risks in oncology.
- Identification of future research directions.
Main Results:
- LLMs can generalize across diverse NLP tasks, with significant potential in oncology due to extensive patient data.
- Potential benefits span patients, oncologists, researchers, and learners, enhancing various aspects of cancer care.
- Identified risks include model hallucinations, data bias, patient privacy concerns, and potential clinician deskilling.
Conclusions:
- LLMs show substantial promise for transforming oncology, but careful consideration of risks is crucial.
- Future research must prioritize patient perspectives, clinical benchmarks, real-world validation, and deeper understanding of LLM reasoning.
Related Concept Videos
Adaptive Mechanisms in Cancer Cells
6.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.9K
Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
Mouse Models of Cancer Study
6.3K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
6.3K
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Cancer Survival Analysis
630
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
630
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K

